Business Context and Reporting Period
Envoy Medical, Inc. (COCH) filed a Form 8-K on February 25, 2025, reporting a deficiency notification from The Nasdaq Stock Market. The company is incorporated in Delaware and operates as an emerging growth company.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity figures. The only financial metric disclosed is the market value of listed securities, which fell below the required minimum of $35,000,000 for 31 consecutive business days between January 7, 2025, and February 24, 2025.
Material Changes
The material change is the loss of compliance with Nasdaq Listing Rule 5550(b)(2) regarding the minimum market value of listed securities. This non-compliance triggered a formal deficiency notification from the exchange.
Outlook, Risks, and Contingencies
The company has a 180-day compliance period expiring on August 25, 2025, to regain compliance. To avoid delisting, the market value of its listed securities must exceed $35,000,000 for ten consecutive business days within this window. Failure to meet this requirement may result in delisting from Nasdaq.
Investor Verification Checklist
- Verify the current market capitalization and daily trading volume to assess the likelihood of regaining compliance.
- Monitor subsequent 8-K filings for updates on the company's compliance status or potential delisting proceedings.
- Review the company's capital structure and any potential equity offerings that could impact share price and market value.
- Confirm the status of the company's Class A Common Stock (COCH) and Redeemable Warrants (COCHW) on Nasdaq.